GlassScriptPhysician profile
Robert W Gilbert
NPI 1235346099
$3,052.15
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $1,477 · 2021: $1,078 · 2023: $99.80 · 2024: $42.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $99.80 · Food and Beverage: $42.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $99.80 |
| Food and Beverage | $42.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $1,056.79 | 2019-2020 | |
| Mdd US Operations, LLC | $402.69 | 2019-2021 | |
| Abbvie INC. | $364.17 | 2021 | |
| Biogen, INC. | $257.48 | 2021-2024 | Vumerity, Tysabri |
| Eisai INC. | $141.45 | 2019-2020 | |
| Amneal Pharmaceuticals LLC | $136.73 | 2020-2021 | |
| Emd Serono, INC. | $99.80 | 2023 | |
| Alexion Pharmaceuticals, INC. | $75.77 | 2019-2020 | |
| Genentech USA, INC. | $66.44 | 2019-2021 | |
| Ucb, INC. | $56.16 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $49.94 | 2021 | |
| Jazz Pharmaceuticals INC. | $49.34 | 2021 | |
| Avanir Pharmaceuticals, INC. | $46.34 | 2019 | |
| Neurocrine Biosciences, INC. | $29.17 | 2021 | |
| Merz Pharmaceuticals, LLC | $28.12 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $25.45 | 2020 | |
| Pfizer INC. | $25.00 | 2021 | |
| Argenx US, INC. | $23.94 | 2024 | Vyvgart Hytrulo |
| Sk Life Science, INC. | $21.86 | 2020 | |
| Celgene Corporation | $20.83 | 2021 | |
| Acadia Pharmaceuticals INC | $18.43 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $18.12 | 2021 | |
| Livanova USA, INC. | $13.21 | 2021 | |
| Lundbeck LLC | $13.09 | 2020 | |
| Zyla Life Sciences, INC. | $11.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.